Khaled Abdelgawwad Selected Research

Khaled Abdelgawwad Research Topics

9	Venous Thromboembolism 05/2024 - 02/2021
9	Hemorrhage 05/2024 - 01/2021
8	Neoplasms (Cancer) 05/2024 - 02/2021
5	Atrial Fibrillation 03/2024 - 01/2021
3	Embolism (Embolus) 03/2024 - 01/2021
2	Renal Insufficiency (Renal Failure) 03/2024 - 01/2023
2	Ischemic Stroke 03/2024 - 02/2024
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2024 - 01/2021
2	Stroke (Strokes) 02/2024 - 01/2021
2	Thrombosis (Thrombus) 04/2023 - 12/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2021
1	Leukemia 07/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Pulmonary Embolism 12/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2021
1	Thromboembolism 01/2021

14	RivaroxabanIBA 05/2024 - 01/2021
5	Warfarin (Coumadin)FDA LinkGeneric 02/2024 - 01/2021
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024 - 01/2023
4	AnticoagulantsIBA 03/2024 - 02/2021
4	apixabanIBA 03/2024 - 10/2021
2	Factor Xa InhibitorsIBA 02/2024 - 04/2023
1	Phenprocoumon (Liquamar)FDA Link 03/2024
1	Vitamin K FDA Link 03/2024
1	Factor Xa (Coagulation Factor Xa)IBA 03/2024
1	Dabigatran FDA Link 02/2024
1	CreatinineIBA 01/2023

2	Therapeutics 12/2021 - 02/2021
1	Kidney Transplantation 01/2023
1	Blood Transfusion (Blood Transfusions) 01/2023
1	Catheters 12/2021
1	Oral Administration 02/2021